Correlation Between ZyVersa Therapeutics and Biomx
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Biomx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Biomx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Biomx Inc, you can compare the effects of market volatilities on ZyVersa Therapeutics and Biomx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Biomx. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Biomx.
Diversification Opportunities for ZyVersa Therapeutics and Biomx
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between ZyVersa and Biomx is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Biomx Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomx Inc and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Biomx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomx Inc has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Biomx go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Biomx
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Biomx. In addition to that, ZyVersa Therapeutics is 2.15 times more volatile than Biomx Inc. It trades about -0.16 of its total potential returns per unit of risk. Biomx Inc is currently generating about -0.31 per unit of volatility. If you would invest 87.00 in Biomx Inc on August 29, 2024 and sell it today you would lose (32.00) from holding Biomx Inc or give up 36.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Biomx Inc
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Biomx Inc |
ZyVersa Therapeutics and Biomx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Biomx
The main advantage of trading using opposite ZyVersa Therapeutics and Biomx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Biomx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomx will offset losses from the drop in Biomx's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Biomx vs. ZyVersa Therapeutics | Biomx vs. Immix Biopharma | Biomx vs. Cns Pharmaceuticals | Biomx vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |